Andreas Rank
University of Augsburg
5 Papers
11 Citations
Andreas Rank is an academic researcher from University of Augsburg. The author has contributed to research in topics: Immune system & Lymphocyte. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Sustained cellular immunity in adults recovered from mild COVID-19.
Andreas Rank,Phillip Löhr,Reinhard Hoffmann,Alanna Ebigbo,Stefanie Grützner,C. Schmid,Rainer Claus +6 more
TL;DR: In this paper, the authors demonstrate by extensive lymphocyte profiling in 44 adults after mild COVID-19 that cellular immunity is not fundamentally altered in convalescent patients, except for increased activated CD8+ lymphocytes.
11
Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Andreas Rank,Christophe Peczynski,M. Labopin,Matthias Stelljes,Célestine Simand,Grzegorz Helbig,Jürgen Finke,Stella Santarone,Johanna Tischer,Andrzej Lange,Martin Mistrik,Mohamed Houhou,C. Schmid,Arnon Nagler,Mohamad Mohty +14 more
- 01 May 2021
TL;DR: Results after a third alloSCT are poor, limiting this procedure to few, highly selected patients, and recurrent relapses of acute leukemia after alloS CT remain an unmet therapeutic need.
8
Sarcoid-like reactions: a potential pitfall in oncologic imaging.
TL;DR: A 44-year-old female with the primary diagnosis of classic Hodgkin’s lymphoma with the absence of clinical symptoms was referred for further diagnostic work-up, supporting the hypothesis of a tumorrelated sarcoid-like reaction.
Impact of age and gender on lymphocyte subset counts in patients with COVID-19.
Phillip Löhr,Stefan Schiele,Tim Tobias Arndt,Stefanie Grützner,Rainer Claus,Christoph Römmele,Gernot Müller,C. Schmid,Kevin M. Dennehy,Andreas Rank +9 more
TL;DR: In this article, the impact of age and gender on a large variety of lymphocyte subsets was analyzed in 33 symptomatic patients with acute Coronavirus disease 2019 (COVID-19) and compared with cell counts in 50 healthy humans.
One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms.
Andreas Rank,Athanasia Tzortzini,Elisabeth Kling,C. Schmid,Rainer Claus,Eva Löll,Roswitha Burger,Christoph Römmele,Christine Dhillon,Katharina Müller,Philipp Girl,Reinhard Hoffmann,Stefanie Grützner,Kevin M. Dennehy +13 more
TL;DR: In this paper, the authors focused on mild COVID-19 and investigated correlations of immunity with persistent symptoms and immune longevity, and found a weak correlation between long-term loss of taste/smell and low IgA levels at early time points.